Sensus Healthcare (SRTS) Competitors $4.79 +0.18 (+3.90%) As of 04:00 PM Eastern Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock SRTS vs. LUNG, ZIMV, SNWV, NNOX, SMTI, NVRO, RCEL, NYXH, INGN, and ELMDShould you be buying Sensus Healthcare stock or one of its competitors? The main competitors of Sensus Healthcare include Pulmonx (LUNG), ZimVie (ZIMV), SANUWAVE Health (SNWV), Nano-X Imaging (NNOX), Sanara MedTech (SMTI), Nevro (NVRO), AVITA Medical (RCEL), Nyxoah (NYXH), Inogen (INGN), and Electromed (ELMD). These companies are all part of the "medical equipment" industry. Sensus Healthcare vs. Pulmonx ZimVie SANUWAVE Health Nano-X Imaging Sanara MedTech Nevro AVITA Medical Nyxoah Inogen Electromed Pulmonx (NASDAQ:LUNG) and Sensus Healthcare (NASDAQ:SRTS) are both small-cap medical companies, but which is the superior stock? We will compare the two businesses based on the strength of their institutional ownership, dividends, media sentiment, profitability, analyst recommendations, community ranking, valuation, earnings and risk. Which has more risk and volatility, LUNG or SRTS? Pulmonx has a beta of 0.61, indicating that its share price is 39% less volatile than the S&P 500. Comparatively, Sensus Healthcare has a beta of 1.11, indicating that its share price is 11% more volatile than the S&P 500. Does the media favor LUNG or SRTS? In the previous week, Pulmonx had 3 more articles in the media than Sensus Healthcare. MarketBeat recorded 5 mentions for Pulmonx and 2 mentions for Sensus Healthcare. Pulmonx's average media sentiment score of 1.24 beat Sensus Healthcare's score of 0.58 indicating that Pulmonx is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Pulmonx 3 Very Positive mention(s) 1 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Sensus Healthcare 1 Very Positive mention(s) 0 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Is LUNG or SRTS more profitable? Sensus Healthcare has a net margin of 15.90% compared to Pulmonx's net margin of -67.31%. Sensus Healthcare's return on equity of 12.60% beat Pulmonx's return on equity.Company Net Margins Return on Equity Return on Assets Pulmonx-67.31% -55.36% -33.53% Sensus Healthcare 15.90%12.60%11.38% Do analysts recommend LUNG or SRTS? Pulmonx currently has a consensus target price of $12.75, suggesting a potential upside of 135.67%. Sensus Healthcare has a consensus target price of $13.00, suggesting a potential upside of 171.40%. Given Sensus Healthcare's stronger consensus rating and higher possible upside, analysts plainly believe Sensus Healthcare is more favorable than Pulmonx.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Pulmonx 0 Sell rating(s) 2 Hold rating(s) 6 Buy rating(s) 0 Strong Buy rating(s) 2.75Sensus Healthcare 0 Sell rating(s) 0 Hold rating(s) 3 Buy rating(s) 1 Strong Buy rating(s) 3.25 Do institutionals & insiders believe in LUNG or SRTS? 91.0% of Pulmonx shares are held by institutional investors. Comparatively, 25.3% of Sensus Healthcare shares are held by institutional investors. 5.7% of Pulmonx shares are held by insiders. Comparatively, 9.4% of Sensus Healthcare shares are held by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock will outperform the market over the long term. Does the MarketBeat Community favor LUNG or SRTS? Sensus Healthcare received 150 more outperform votes than Pulmonx when rated by MarketBeat users. Likewise, 68.89% of users gave Sensus Healthcare an outperform vote while only 45.57% of users gave Pulmonx an outperform vote. CompanyUnderperformOutperformPulmonxOutperform Votes3645.57% Underperform Votes4354.43% Sensus HealthcareOutperform Votes18668.89% Underperform Votes8431.11% Which has higher earnings and valuation, LUNG or SRTS? Sensus Healthcare has lower revenue, but higher earnings than Pulmonx. Pulmonx is trading at a lower price-to-earnings ratio than Sensus Healthcare, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioPulmonx$83.79M2.60-$60.84M-$1.44-3.76Sensus Healthcare$41.81M1.89$6.65M$0.4011.98 SummarySensus Healthcare beats Pulmonx on 13 of the 19 factors compared between the two stocks. Remove Ads Get Sensus Healthcare News Delivered to You Automatically Sign up to receive the latest news and ratings for SRTS and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart SRTS vs. The Competition Export to ExcelMetricSensus HealthcareSurgical & medical instruments IndustryMedical SectorNASDAQ ExchangeMarket Cap$79.01M$4.10B$5.36B$7.62BDividend YieldN/A39.53%5.11%4.33%P/E Ratio11.9827.6221.7117.82Price / Sales1.8946.33376.1094.32Price / Cash96.2951.0838.1534.64Price / Book1.615.826.444.00Net Income$6.65M$67.09M$3.20B$247.24M7 Day Performance6.92%2.02%6.23%5.82%1 Month Performance3.01%-6.39%-6.64%-5.82%1 Year Performance41.72%11.12%8.19%-1.90% Sensus Healthcare Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)SRTSSensus Healthcare1.7585 of 5 stars$4.79+3.9%$13.00+171.4%+36.4%$79.01M$41.81M11.9840Gap DownLUNGPulmonx2.6325 of 5 stars$6.60-2.4%$12.75+93.2%-33.5%$262.65M$83.79M-4.58250News CoveragePositive NewsZIMVZimVie2.2478 of 5 stars$9.34-1.4%$23.00+146.3%-42.5%$260.09M$449.75M-0.712,700Analyst RevisionNews CoverageSNWVSANUWAVE HealthN/A$30.18-1.6%N/AN/A$258.01M$32.63M-7.7440High Trading VolumeNNOXNano-X Imaging1.8476 of 5 stars$4.41+0.2%$12.00+172.1%-52.5%$254.81M$11.28M-5.19190Gap DownSMTISanara MedTech1.7717 of 5 stars$27.55-0.9%$48.50+76.0%-13.3%$245.25M$86.67M-27.8360High Trading VolumeNVRONevro0.8416 of 5 stars$5.85+0.1%$6.43+9.9%-55.8%$224.32M$408.52M-3.091,215RCELAVITA Medical1.2987 of 5 stars$7.76+3.5%$17.25+122.3%-12.8%$203.45M$64.25M-3.25130NYXHNyxoah1.9516 of 5 stars$5.71-6.1%$14.75+158.3%-31.7%$194.48M$4.52M-3.05110Short Interest ↑Gap UpINGNInogen2.9723 of 5 stars$7.09+0.7%$7.00-1.3%-0.7%$190.63M$335.71M-3.151,030Short Interest ↓News CoveragePositive NewsHigh Trading VolumeELMDElectromed1.0644 of 5 stars$22.16-1.0%$38.00+71.5%+55.0%$189.62M$59.63M29.55160Positive News Remove Ads Related Companies and Tools Related Companies LUNG Alternatives ZIMV Alternatives SNWV Alternatives NNOX Alternatives SMTI Alternatives NVRO Alternatives RCEL Alternatives NYXH Alternatives INGN Alternatives ELMD Alternatives Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:SRTS) was last updated on 4/14/2025 by MarketBeat.com Staff From Our PartnersThe biggest story CNBC isn't talking about (yet)This Story Could Go Viral as Soon as May 31 Quietly, towns like Shreveport, Louisiana and Fort Worth, Texas...Stansberry Research | SponsoredCollect $7k per month from Tesla’s SECRET dividendTesla doesn't pay a traditional dividend.... But I just discovered a secret backdoor to collect a secret 69...Investors Alley | SponsoredIf Gold Is ‘Stalling,’ Why Are Banks Hoarding Billions In Secret?Prosperity was something every American family could build, protect, and pass down. Because that's what legacy...Colonial Metals | SponsoredBITCOINDid you miss out on the 1000%+ gains of Bitcoin over the past 5 years? If so, you don't want to miss this.....Awesomely, LLC | SponsoredElon Musk is helping print “new gold”MIT scientists just developed a brand-new metal… A metal that’s shaping up to be, not only the biggest brea...True Market Insiders | SponsoredTrump’s Secret WeaponHave you looked at the stock market recently? Millions of investors are scrambling trying to figure out what's...American Alternative | SponsoredDeFi Coin on Verge of Breakout!Crypto’s down — but the fundamentals aren’t. Strategic investors are using this dip to scoop up undervalued...Crypto 101 Media | SponsoredCatastrophicThe losses are catastrophic... $760 billion wiped off the Magnificent 7, in a single day.InvestorPlace | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Sensus Healthcare, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Sensus Healthcare With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
